The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Causes and Outcomes of the Acute Chest Syndrome in Sickle Cell Disease
Open accessAbstract
BACKGROUND: The acute chest syndrome is the leading cause of death among patients with sickle cell disease. Since its cause is largely unknown, therapy is supportive. Pilot studies with improved diagnostic techniques suggest that infection and fat embolism are underdiagnosed in patients with the syndrome. METHODS: In a 30-center study, we analyzed 671 episodes of the acute chest syndrome in 538 patients with sickle cell disease to determine the cause, outcome, and response to therapy. We evaluated a treatment protocol that included matched transfusions, bronchodilators, and bronchoscopy. Samples of blood and respiratory tract secretions were sent to central laboratories for antibody testing, culture, DNA testing, and histopathological analyses. RESULTS: Nearly half the patients were initially admitted for another reason, mainly pain. When the acute chest syndrome was diagnosed, patients had hypoxia, decreasing hemoglobin values, and progressive multilobar pneumonia. The mean length of hospitalization was 10.5 days. Thirteen percent of patients required mechanical ventilation, and 3 percent died. Patients who were 20 or more years of age had a more severe course than those who were younger. Neurologic events occurred in 11 percent of patients, among whom 46 percent had respiratory failure. Treatment with phenotypically matched transfusions improved oxygenation, with a 1 percent rate of alloimmunization. One fifth of the patients who were treated with bronchodilators had clinical improvement. Eighty-one percent of patients who required mechanical ventilation recovered. A specific cause of the acute chest syndrome was identified in 38 percent of all episodes and 70 percent of episodes with complete data. Among the specific causes were pulmonary fat embolism and 27 different infectious pathogens. Eighteen patients died, and the most common causes of death were pulmonary emboli and infectious bronchopneumonia. Infection was a contributing factor in 56 percent of the deaths. CONCLUSIONS: Among patients with sickle cell disease, the acute chest syndrome is commonly precipitated by fat embolism and infection, especially community-acquired pneumonia. Among older patients and those with neurologic symptoms, the syndrome often progresses to respiratory failure. Treatment with transfusions and bronchodilators improves oxygenation, and with aggressive treatment, most patients who have respiratory failure recover.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Epidemiologically, ACS is a complication of VOC, based on its typical development 2–3 days after the onset of vaso-occlusive pain (111)”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [111]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“it is more common in children and, if untreated, has a high mortality [9% in adults (111)].”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [111]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mortality in sickle cell disease. Life expectancy and risk factors for early death
Platt, O. S., Brambilla, D. J., Rosse, W. F., Milner, P. F., Castro, O., Steinberg, M. H., & Klug, P. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302303 · Cited by 3,320
Rickinson, A. B. (2002) · PubMed · doi:10.1016/s0168-1702(01)00436-1 · Cited by 2,182
Cerebrovascular accidents in sickle cell disease: rates and risk factors.
(1998) · PubMed · doi:10.1182/blood.v91.1.288 · Cited by 1,694
Incidence of and Risk Factors for Ventilator-Associated Pneumonia in Critically Ill Patients
Cook, D. J., Walter, S. D., Cook, R. J., Griffith, L. E., Guyatt, G. H., Leasa, D., Jaeschke, R. Z., & Brun‐Buisson, C. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-6-199809150-00002 · Cited by 1,108
Castro, O. L., Brambilla, D. J., Thorington, B. D., Reindorf, C. A., Scott, R., GILLETTE, P. N., Vera, J., & Levy, P. S. (1994) · Blood · doi:10.1182/blood.v84.2.643.643 · Cited by 805
Vichinsky, E. P., Haberkern, C. M., Neumayr, L., Earles, A. N., Black, D. M., Koshy, M., Pegelow, C. H., Abboud, M. R., Ohene‐Frempong, K., & Iyer, R. V. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507273330402 · Cited by 644
Self-citationCastro, O. L., Brambilla, D. J., Thorington, B. D., et al. (1994) · Blood · doi:10.1182/blood.v84.2.643.bloodjournal842643 · Cited by 615
Acute Chest Syndrome in Sickle Cell Disease: Clinical Presentation and Course
Vichinsky, E. P., Styles, L. A., Colangelo, L. H., Wright, E. C., Castro, O., Nickerson, B., & Disease, T. C. S. O. S. C. (1997) · Blood · doi:10.1182/blood.v89.5.1787 · Cited by 573
Self-citationSickle cell chronic lung disease: prior morbidity and the risk of pulmonary failure.
Powars, D., WEIDMAN, J. A., Odom‐Maryon, T., Niland, J. C., & Johnson, C. M. (1988) · PubMed · Cited by 329
Sickle Cell Chronic Lung Disease
Powars, D. R., WEIDMAN, J. A., ODOM-MARYON, T., Niland, J. C., & Johnson, C. S. (1988) · Medicine · doi:10.1097/00005792-198801000-00005 · Cited by 283
Research works printed but not linked: 9
- Vichinsky E, 1991, Semin Hematol, 28, 220
- Sprinkle RH, 1986, Am J Pediatr Hematol Oncol, 8, 105
- Landry ML, Hsiung GD. Primary isolation of viruses. In: Specter S, Lancz G, eds. Clinical virology manual. 2nd ed. New York: Elsevier Science Publishing, 1992:43-69.
- Waites KB, Taylor-Robinson D. Mycoplasma and Ureaplasma. In: Murray PR, ed. Manual of clinical microbiology. 7th ed. Washington, D.C.: ASM Press, 1999:782-806.
- Lennette ET, Lennette DA. Immune adherence hemagglutination. In: Specter S, Lancz G, eds. Clinical virology manual. 2nd ed. New York: Elsevier Science Publishing, 1992:251-61.
- Schachter J. Chlamydiae. In: Balows A, Hausler WJ Jr, Hermann KL, Isenberg HD, Shadomy HJ, eds. Manual of clinical microbiology. 5th ed. Washington, D.C.: ASM Press, 1991:1045-53.
- Ohene-Frempong K, 1998, Blood, 91, 288
- Mallouh AA, 1988, Am J Dis Child, 142, 178
- Ibe BO, 1997, Am J Physiol, 272, L597
Cited by
Sorted by citations
Rees, D. C., Williams, T. N., & Gladwin, M. T. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61029-x · Cited by 2,504
Padmanabhan, A., Connelly‐Smith, L. S., Aqui, N. A., Balogun, R. A., Klingel, R., Meyer, E., Pham, H. P., Schneiderman, J., Witt, V., Wu, Y., et al. (2019) · Journal of Clinical Apheresis · doi:10.1002/jca.21705 · Cited by 2,245
Piel, F. B., Steinberg, M. H., & Rees, D. C. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1510865 · Cited by 1,488
Management of Sickle Cell Disease: Summary of the 2014 Evidence-Based Report by Expert Panel Members
Yawn, B. P., Buchanan, G. R., Afenyi-Annan, A. N., Ballas, S. K., Hassell, K. L., James, A. H., Jordan, L., Lanzkron, S. M., Lottenberg, R., Savage, W. J., et al. (2014) · JAMA · doi:10.1001/jama.2014.10517 · Cited by 1,599
Self-citationKato, G. J., Piel, F. B., Reid, C. D., Gaston, M. H., Ohene-Frempong, K., Krishnamurti, L., Smith, W. R., Panepinto, J. A., Weatherall, D. J., Costa, F. F., et al. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.10 · Cited by 1,501
Self-citationEffect of Hydroxyurea on Mortality and Morbidity in Adult Sickle Cell Anemia
Steinberg, M. H., Barton, F. B., Castro, O. L., Pegelow, C. H., Ballas, S. K., Kutlar, A., Orringer, E. P., Bellevue, R., Olivieri, N. F., Eckman, J. R., et al. (2003) · JAMA · doi:10.1001/jama.289.13.1645 · Cited by 928
Self-citationStuart, M. J., & Nagel, R. L. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17192-4 · Cited by 867
Pathophysiology of Sickle Cell Disease
Sundd, P., Gladwin, M. T., & Novelli, E. M. (2019) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012838 · Cited by 813
Schwartz, J. E., Padmanabhan, A., Aqui, N. A., Balogun, R. A., Connelly‐Smith, L. S., Delaney, M., Dunbar, N. M., Witt, V., Wu, Y., & Shaz, B. H. (2016) · Journal of Clinical Apheresis · doi:10.1002/jca.21470 · Cited by 799
Connelly‐Smith, L. S., Alquist, C. R., Aqui, N. A., Hofmann, J. C., Klingel, R., Onwuemene, O. A., Patriquin, C. J., Pham, H. P., Sanchez, A. P., Schneiderman, J., et al. (2023) · Journal of Clinical Apheresis · doi:10.1002/jca.22043 · Cited by 736
Piel, F. B., Steinberg, M., & Rees, D. C. (2016) · Spiral (Imperial College London) · doi:10.1056/nejmc1706325#sa6 · Cited by 662
Schwartz, J. E., Winters, J. L., Padmanabhan, A., Balogun, R. A., Delaney, M., Linenberger, M. L., Szczepiorkowski, Z. M., Williams, M. E., Wu, Y., & Shaz, B. H. (2013) · Journal of Clinical Apheresis · doi:10.1002/jca.21276 · Cited by 610
A Phase 3 Trial of l -Glutamine in Sickle Cell Disease
Niihara, Y., Miller, S. T., Kanter, J., Lanzkron, S., Smith, W. R., Hsu, L. L.-Y., Gordeuk, V. R., Viswanathan, K., Sarnaik, S. A., Osunkwo, I., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1715971 · Cited by 568
Self-citationSzczepiorkowski, Z. M., Bandarenko, N., Kim, H. C., Linenberger, M. L., Marques, M. B., Sarode, R., Schwartz, J. E., Shaz, B. H., Weinstein, R. S., Wirk, A., et al. (2007) · Journal of Clinical Apheresis · doi:10.1002/jca.20129 · Cited by 546
American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support
Chou, S. T., Alsawas, M., Fasano, R. M., Field, J. J., Hendrickson, J. E., Howard, J., Kameka, M., Kwiatkowski, J. L., Pirenne, F., Shi, P. A., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019001143 · Cited by 506
Szczepiorkowski, Z. M., Winters, J. L., Bandarenko, N., Kim, H. C., Linenberger, M. L., Marques, M. B., Sarode, R., Schwartz, J. E., Weinstein, R. S., & Shaz, B. H. (2010) · Journal of Clinical Apheresis · doi:10.1002/jca.20240 · Cited by 506
Primary role for adherent leukocytes in sickle cell vascular occlusion: A new paradigm
Turhan, A., Weiss, L. A., Mohandas, N., Coller, B. S., & Frenette, P. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052522799 · Cited by 487
Red blood cell transfusion in clinical practice
Klein, H. G., Spahn, D. R., & Carson, J. L. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61197-0 · Cited by 479
Kavanagh, P. L., Fasipe, T., & Wun, T. (2022) · JAMA · doi:10.1001/jama.2022.10233 · Cited by 522
Entering the Modern Era of Gene Therapy
Anguela, X. M., & High, K. A. (2018) · Annual Review of Medicine · doi:10.1146/annurev-med-012017-043332 · Cited by 493
Pulmonary Complications of Sickle Cell Disease
Gladwin, M. T., & Vichinsky, E. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0804411 · Cited by 470
Self-citationThe Endothelial Biology of Sickle Cell Disease: Inflammation and a Chronic Vasculopathy
Hebbel, R. P., Osarogiagbon, R. U., & Kaul, D. K. (2004) · Microcirculation · doi:10.1080/10739680490278402 · Cited by 464
Definitions of the phenotypic manifestations of sickle cell disease
Ballas, S. K., Lieff, S., Benjamin, L. J., Dampier, C., Heeney, M. M., Hoppe, C. C., Johnson, C. S., Rogers, Z. R., Smith‐Whitley, K., Wang, W. C., et al. (2009) · American Journal of Hematology · doi:10.1002/ajh.21550 · Cited by 454
Self-citationSickle cell pain: a critical reappraisal
Ballas, S. K., Gupta, K., & Adams-Graves, P. E. (2012) · Blood · doi:10.1182/blood-2012-04-383430 · Cited by 442
Self-citationInfection in sickle cell disease: A review
Booth, C., Inusa, B. P. D., & Obaro, S. (2009) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2009.03.010 · Cited by 355
Heme-induced neutrophil extracellular traps contribute to the pathogenesis of sickle cell disease
Chen, G., Zhang, D., Fuchs, T. A., Manwani, D., Wagner, D. D., & Frenette, P. S. (2014) · Blood · doi:10.1182/blood-2013-10-529982 · Cited by 354
Vichinsky, E. P., Luban, N. L. C., Wright, E. C., Olivieri, N. F., Driscoll, C. E., Pegelow, C. H., Adams, R. J., & Anemia, F. T. S. P. T. I. S. C. (2001) · Transfusion · doi:10.1046/j.1537-2995.2001.41091086.x · Cited by 338
Self-citationSteinberg, M. H. (2008) · The Scientific World JOURNAL · doi:10.1100/tsw.2008.157 · Cited by 306
Sickle cell disease related mortality in the United States (1999-2009)
Hamideh, D., & Alvarez, O. A. (2013) · Pediatric Blood & Cancer · doi:10.1002/pbc.24557 · Cited by 290
Leukocytosis and Ischemic Vascular Disease Morbidity and Mortality: Is It Time to Intervene?
Coller, B. S. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000156877.94472.a5 · Cited by 286
Extracellular hemin crisis triggers acute chest syndrome in sickle mice
Ghosh, S., Adisa, O. A., Chappa, P., Tan, F., Jackson, K. A., Archer, D. R., & Ofori-Acquah, S. F. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64578 · Cited by 282
Guidelines for the management of the acute painful crisis in sickle cell disease
Rees, D. C., Olujohungbe, A. D., Parker, N. E., Stephens, A. D., Telfer, P. T., & Wright, J. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04193.x · Cited by 280
Selvaraj, S. K., Giri, R. K., Perelman, N., Johnson, C. S., Malik, P., & Kalra, V. K. (2003) · Blood · doi:10.1182/blood-2002-11-3423 · Cited by 268
Klings, E. S., Machado, R. F., Barst, R. J., Morris, C. R., Mubarak, K. K., Gordeuk, V. R., Kato, G. J., Ataga, K. I., Gibbs, J. S. R., Castro, O. L., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201401-0065st · Cited by 264
Lonergan, G. J., Cline, D. B., & Abbondanzo, S. L. (2001) · Radiographics · doi:10.1148/radiographics.21.4.g01jl23971 · Cited by 254
Asthma is associated with acute chest syndrome and pain in children with sickle cell anemia
Boyd, J. H., Macklin, E. A., Strunk, R. C., & DeBaun, M. R. (2006) · Blood · doi:10.1182/blood-2006-01-011072 · Cited by 253
The vaso‐occlusive pain crisis in sickle cell disease: Definition, pathophysiology, and management
Darbari, D. S., Sheehan, V., & Ballas, S. K. (2020) · European Journal Of Haematology · doi:10.1111/ejh.13430 · Cited by 256
Self-citationDeep Venous Thrombosis and Pulmonary Embolism in Hospitalized Patients with Sickle Cell Disease
Stein, P. D., Beemath, A., Meyers, F. A., Skaf, E., & Olson, R. E. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.08.015 · Cited by 241
Sickle cell disease: a neglected chronic disease of increasing global health importance
Chakravorty, S., & Williams, T. N. (2014) · Archives of Disease in Childhood · doi:10.1136/archdischild-2013-303773 · Cited by 237
Castro, O. L., Sandler, S. G., Houston‐Yu, P., & RANA, S. R. (2002) · Transfusion · doi:10.1046/j.1537-2995.2002.00126.x · Cited by 225
Nitric Oxide for Inhalation in the Acute Treatment of Sickle Cell Pain Crisis
Gladwin, M. T. (2011) · JAMA · doi:10.1001/jama.2011.235 · Cited by 223
Endothelial pathomechanisms in acute lung injury
Maniatis, N. A., Kotanidou, A. N., Catravas, J. D., & Orfanos, S. E. (2008) · Vascular Pharmacology · doi:10.1016/j.vph.2008.06.009 · Cited by 219
Telen, M. J., Wun, T., McCavit, T. L., De Castro, L. M., Krishnamurti, L., Lanzkron, S., Hsu, L. L., Smith, W. R., Rhee, S., Magnani, J. L., et al. (2015) · Blood · doi:10.1182/blood-2014-06-583351 · Cited by 211
Genetic Etiologies for Phenotypic Diversity in Sickle Cell Anemia
Steinberg, M. H. (2009) · The Scientific World JOURNAL · doi:10.1100/tsw.2009.10 · Cited by 206
Asthma in children with sickle cell disease and its association with acute chest syndrome
Knight‐Madden, J. (2005) · Thorax · doi:10.1136/thx.2004.029165 · Cited by 199
Sickle cell disease: when and how to transfuse
Howard, J. (2016) · Hematology · doi:10.1182/asheducation-2016.1.625 · Cited by 197
Claster, S., & Vichinsky, E. P. (2003) · BMJ · doi:10.1136/bmj.327.7424.1151 · Cited by 196
Self-citationBallas, S. K., Kesen, M. R., Goldberg, M. F., Lutty, G. A., Dampier, C., Osunkwo, I., Wang, W. C., Hoppe, C. C., Hagar, W., Darbari, D. S., et al. (2012) · The Scientific World JOURNAL · doi:10.1100/2012/949535 · Cited by 198
Self-citationHealth Supervision for Children with Sickle Cell Disease
Section on Hematology/Oncology and Committee on Genetics (2002) · PEDIATRICS · doi:10.1542/peds.109.3.526 · Cited by 191
Nonthrombotic pulmonary embolism
Jorens, P. G., Marck, E. V., Snoeckx, A., & Parizel, P. M. (2009) · European Respiratory Journal · doi:10.1183/09031936.00141708 · Cited by 185
Guideline on the management of acute chest syndrome in sickle cell disease
Howard, J., Hart, N., Roberts-Harewood, M., Cummins, M., Awogbade, M., & Davis, B. A. (2015) · British Journal of Haematology · doi:10.1111/bjh.13348 · Cited by 186
Red Cell Exchange in Sickle Cell Disease
Swerdlow, P. S. (2006) · Hematology · doi:10.1182/asheducation-2006.1.48 · Cited by 186
Piel, F. B., Rees, D. C., DeBaun, M. R., Nnodu, O. E., Ranque, B., Thompson, A. A., Ware, R. E., Abboud, M. R., Abraham, A., Ambrose, E. E., et al. (2023) · The Lancet Haematology · doi:10.1016/s2352-3026(23)00096-0 · Cited by 203
Self-citationSickle cell disease; a general overview.
Schnog, J. B., Duits, A. J., Muskiet, F. A. J., Cate, H. T., Rojer, R. A., & Brandjes, D. P. M. (2004) · PubMed · Cited by 184
Kim, K. S., Rajagopal, V., Gonsalves, C. S., Johnson, C. S., & Kalra, V. K. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.7211 · Cited by 180
Pulmonary Complications of Sickle Cell Disease
Miller, A. C., & Gladwin, M. T. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201111-2082ci · Cited by 188
Sickle Cell Disease: New Opportunities and Challenges in Africa
Makani, J., Ofori-Acquah, S. F., Nnodu, O. E., Wonkam, A., & Ohene‐Frempong, K. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/193252 · Cited by 180
Prevalence and reversibility of lower airway obstruction in children with sickle cell disease
Koumbourlis, A. C., Zar, H. J., Hurlet‐Jensen, A., & Goldberg, M. R. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.111824 · Cited by 173
Acute Chest Syndrome in Children with Sickle Cell Disease
Jain, S., Bakshi, N., & Krishnamurti, L. (2017) · Pediatric Allergy Immunology and Pulmonology · doi:10.1089/ped.2017.0814 · Cited by 170
Pulmonary Hypertension and Cor Pulmonale during Severe Acute Chest Syndrome in Sickle Cell Disease
Dessap, A. M., Rusel, L., Habibi, A., Nzouakou, R., Roudot‐Thoraval, F., Adnot, S., Godeau, B., Galactéros, F., Brun‐Buisson, C., Brochard, L. J., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200710-1606oc · Cited by 168
Novelli, E. M., & Gladwin, M. T. (2015) · CHEST Journal · doi:10.1016/j.chest.2015.12.016 · Cited by 166
Understanding Sickle cell disease: Causes, symptoms, and treatment options
Elendu, C., Amaechi, D. C., Alakwe-Ojimba, C. E., Elendu, T. C., Elendu, R. C., Ayabazu, C. P., Aina, T. O., Aborisade, O., & Adenikinju, J. S. (2023) · Medicine · doi:10.1097/md.0000000000035237 · Cited by 189
Lê, P.-Q., Gulbis, B., Dedeken, L., Dupont, S., Vanderfaeillie, A., Heijmans, C., Huybrechts, S., Devalck, C., Efira, A., Dresse, M., et al. (2015) · Pediatric Blood & Cancer · doi:10.1002/pbc.25608 · Cited by 164
Pathophysiology of pulmonary hypertension in acute lung injury
Price, L., McAuley, D. F., Marino, P. S., Finney, S. J., Griffiths, M., & Wort, S. J. (2012) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00355.2011 · Cited by 163
Differences in the clinical and genotypic presentation of sickle cell disease around the world
Saraf, S. L., Molokie, R. E., Nouraie, M. S., Sable, C., Luchtman‐Jones, L., Ensing, G. J., Campbell, A., RANA, S. R., Niu, X. M., Machado, R. F., et al. (2013) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2013.11.003 · Cited by 172
Treating influenza with statins and other immunomodulatory agents
Fedson, D. S. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.06.018 · Cited by 162
Ballas, S. K. (2002) · Drugs · doi:10.2165/00003495-200262080-00003 · Cited by 158
Self-citationLife-Threatening Infectious Complications in Sickle Cell Disease: A Concise Narrative Review
Ochocinski, D., Dalal, M., Black, L. V., Carr, S. B., Lew, J., Sullivan, K., & Kissoon, N. “. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.00038 · Cited by 162
Biomarkers in sickle cell disease
Rees, D. C., & Gibson, J. S. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08961.x · Cited by 159
Epidemiology of human parvovirus B19 in children with sickle cell disease
Smith‐Whitley, K., Zhao, H., Hodinka, R. L., Kwiatkowski, J., Cecil, R., Cecil, T., Cnaan, A., & Ohene‐Frempong, K. (2003) · Blood · doi:10.1182/blood-2003-01-0069 · Cited by 152
Pulmonary Artery Thrombosis during Acute Chest Syndrome in Sickle Cell Disease
Dessap, A. M., Deux, J.-F., Abidi, N., Lavenu-Bombled, C., Melica, G., Renaud, B., Godeau, B., Adnot, S., Brochard, L., Brun-Buisson, C., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201105-0783oc · Cited by 144
Sickle Cell Anemia and Its Phenotypes
Williams, T. N., & Thein, S. L. (2018) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-083117-021320 · Cited by 165
Pathology of Berkeley sickle cell mice: similarities and differences with human sickle cell disease
Manci, E. A. (2006) · Blood · doi:10.1182/blood-2005-07-2839 · Cited by 149
Self-citationSabaa, N., Franceschi, L. D., Bonnin, P., Castier, Y., Malpeli, G., Debbabi, H., Galaup, A., Maïer-Redelsperger, M., Vandermeersch, S., Scarpa, A., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33308 · Cited by 145
Lung vaso-occlusion in sickle cell disease mediated by arteriolar neutrophil-platelet microemboli
Bennewitz, M. F., Jimenez, M. A., Vats, R., Tutuncuoglu, E., Jonassaint, J., Kato, G. J., Gladwin, M. T., & Sundd, P. (2017) · JCI Insight · doi:10.1172/jci.insight.89761 · Cited by 139
Noubouossie, D. F., Key, N. S., & Ataga, K. I. (2015) · Blood Reviews · doi:10.1016/j.blre.2015.12.003 · Cited by 141
C-Reactive Protein Levels and Viable Chlamydia pneumoniae in Carotid Artery Atherosclerosis
Johnston, S. C., Messina, L. M., Browner, W. S., Lawton, M. T., Morris, C., & Dean, D. (2001) · Stroke · doi:10.1161/hs1201.099631 · Cited by 139
Self-citationRecommandations françaises de prise en charge de la drépanocytose de l'adulte : actualisation 2015
Habibi, A., Arlet, J. B., Stankovic, K., Gellen‐Dautremer, J., Ribeil, J., Bartolucci, P., & Lionnet, F. (2015) · La Revue de Médecine Interne · doi:10.1016/s0248-8663(15)60002-9 · Cited by 137
Transfusion therapy for sickle cell disease: a balancing act
Chou, S. T. (2013) · Hematology · doi:10.1182/asheducation-2013.1.439 · Cited by 136
Role of free radicals in the pathogenesis of acute chest syndrome in sickle cell disease
Klings, E. S., & Farber, H. W. (2001) · Respiratory Research · doi:10.1186/rr70 · Cited by 132
How I treat and manage strokes in sickle cell disease
Kassim, A. A., Galadanci, N. A., Pruthi, S., & DeBaun, M. R. (2015) · Blood · doi:10.1182/blood-2014-09-551564 · Cited by 128
Ischemia-reperfusion Injury in Sickle Cell Anemia
Hebbel, R. P. (2014) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2013.11.005 · Cited by 128
Anxiety and depression in children and adolescents with sickle cell disease
Benton, T. D., Ifeagwu, J. A., & Smith‐Whitley, K. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0080-0 · Cited by 127
Guidelines on red cell transfusion in sickle cell disease Part II : indications for transfusion
Davis, B. A., Allard, S., Qureshi, A., Porter, J. B., Pancham, S., Win, N., Cho, G., Ryan, K. E., & the British Society for Haematology (2016) · British Journal of Haematology · doi:10.1111/bjh.14383 · Cited by 124
Tsitsikas, D. A., Gallinella, G., Patel, S. R., Seligman, H., Greaves, P., & Amos, R. J. (2014) · Blood Reviews · doi:10.1016/j.blre.2013.12.002 · Cited by 123
Pain site frequency and location in sickle cell disease: The PiSCES project
McClish, D. K., Smith, W. R., Dahman, B. A., Levenson, J. L., Roberts, J. D., Penberthy, L. T., Aisiku, I. P., Roseff, S. D., & Bovbjerg, V. E. (2009) · Pain · doi:10.1016/j.pain.2009.06.029 · Cited by 122
Sickle Cell Disease in Sub-Saharan Africa
Williams, T. N. (2016) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2015.11.005 · Cited by 121
Strouse, J. J., Takemoto, C. M., Keefer, J. R., Kato, G. J., & Casella, J. F. (2007) · Pediatric Blood & Cancer · doi:10.1002/pbc.21336 · Cited by 117
Sickle cell disease and venous thromboembolism: what the anticoagulation expert needs to know
Naik, R. P. P., Streiff, M. B., & Lanzkron, S. (2013) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-013-0895-y · Cited by 117
Guidelines on red cell transfusion in sickle cell disease. Part I: principles and laboratory aspects
Davis, B. A., Allard, S., Qureshi, A., Porter, J. B., Pancham, S., Win, N., Cho, G., & Ryan, K. E. (2016) · British Journal of Haematology · doi:10.1111/bjh.14346 · Cited by 114
Yang, L. P. H., Keam, S. J., & Keating, G. M. (2007) · Drugs · doi:10.2165/00003495-200767150-00007 · Cited by 114
Red cell transfusion and alloimmunization in sickle cell disease
Linder, G., & Chou, S. T. (2021) · Haematologica · doi:10.3324/haematol.2020.270546 · Cited by 113
Association of Coagulation Activation with Clinical Complications in Sickle Cell Disease
Ataga, K. I., Brittain, J. E., Desai, P. C., May, R., Jones, S., Delaney, J., Strayhorn, D., Hinderliter, A. L., & Key, N. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029786 · Cited by 112
Ambrusko, S. J., Gunawardena, S. W., Sakara, A., Windsor, B., Lanford, L. M., Michelson, P. H., & Krishnamurti, L. (2006) · Pediatric Blood & Cancer · doi:10.1002/pbc.20791 · Cited by 115
The Acute Chest Syndrome of Sickle Cell Disease
Platt, O. S. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006223422510 · Cited by 112
Luna, G. D., Habibi, A., Deux, J., Colard, M., D'Orengiani, A.-L. P. H. D., Schlemmer, F., Joher, N., Kassasseya, C., Pawlotsky, J., Ourghanlian, C., et al. (2020) · American Journal of Hematology · doi:10.1002/ajh.25833 · Cited by 110
van Beers, E. J., Tuijn, C. F. J. V., Nieuwkerk, P. T., Friederich, P. W., Vranken, J. H., & Biemond, B. J. (2007) · American Journal of Hematology · doi:10.1002/ajh.20944 · Cited by 110
Aliyu, Z. Y., Kato, G. J., Taylor, J. G., Babadoko, A., Mamman, A. I., Gordeuk, V. R., & Gladwin, M. T. (2007) · American Journal of Hematology · doi:10.1002/ajh.21057 · Cited by 115
Management of Patients with Sickle Cell Disease Using Transfusion Therapy
Chou, S. T., & Fasano, R. M. (2016) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2016.01.011 · Cited by 112
Sickle Cell Lung Disease and Sudden Death
Graham, J. K., Mošunjac, M., Hanzlick, R. L., & Mosunjac, M. I. (2007) · American Journal of Forensic Medicine & Pathology · doi:10.1097/01.paf.0000257397.92466.50 · Cited by 107
Metadata
- Authors
- Vichinsky, E. P., Neumayr, L. D., Earles, A. N., Williams, R., Lennette, E. T., Dean, D., Nickerson, B., Orringer, E., McKie, V., Bellevue, R., Daeschner, C., Abboud, M., Moncino, M., Ballas, S., Ware, R., & Manci, E. A.
- Affiliations
- University of California, San Francisco (US)
- Children's Hospital of Orange County (US)
- University of North Carolina at Chapel Hill (US)
- Augusta University (US)
- NewYork–Presbyterian Brooklyn Methodist Hospital (US)
- East Carolina University (US)
- Duke Medical Center (US)
- University of South Alabama Medical Center (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2000-06-22
- Volume
- 342
- Issue
- 25
- Pages
- 1855-1865
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2332642667
- Cited by
- 1,234
- References
- 44
- Citations by year
- 2026: 35 · 2025: 55 · 2024: 52 · 2023: 62 · 2022: 59 · 2021: 67 · 2020: 75 · 2019: 44 · 2018: 48 · 2017: 38 · 2016: 63 · 2015: 51 · 2014: 57 · 2013: 59 · 2012: 51
- FWCI
- 16.73
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- University of Southern California
- University of Miami
- Emory University
- University of South Alabama
- National Institutes of Health (5p60hl020985-25)
- National Heart, Lung, and Blood Institute (HL20985, HL 99016)
- National Center for Research Resources (M01 RR 01271)
- Children's Hospital of Pittsburgh
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Hematology › Blood transfusion and management
- Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
- Keywords
- acute chest syndrome, sickle cell disease, pulmonary fat embolism, infection, community-acquired pneumonia, bronchodilators, bronchoscopy, mechanical ventilation, respiratory failure, neurological complications, mortality, hypoxia
- MeSH terms
- Acute Disease, Adolescent, Adult, Anemia, Sickle Cell, Blood Transfusion, Bronchodilator Agents, Chest Pain, Child, Child, Preschool, Embolism, Fat, Female, Humans, Infections, Lung Diseases, Male, Prospective Studies, Pulmonary Embolism, Respiration, Artificial, Respiratory Insufficiency, Proportional Hazards Models, Community-Acquired Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
